Together, these results suggested inhibition of PI3K/AKT/mTOR signaling at least in part account for the strong inhibitory effect on the growth of disseminated ovarian cancer cells by combined use of BKM120 and Olaparib. This evidence concerns the gene MTOR and ovarian carcinoma.